Probiotics applications in autoimmune diseases
| Main Authors: | Al-Salami, Hani, Caccetta, Rima, Golocorbin-Kon, S., Mikov, M. |
|---|---|
| Other Authors: | Everlon Cid Rigobelo |
| Format: | Book Chapter |
| Published: |
Intech Worldwide Publishing Co. Inc
2012
|
| Online Access: | http://hdl.handle.net/20.500.11937/40160 |
Similar Items
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2012)
by: Al-Salami, Hani, et al.
Published: (2012)
Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017)
by: Mikov, M., et al.
Published: (2017)
Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats
by: Al-Salami, Hani, et al.
Published: (2008)
by: Al-Salami, Hani, et al.
Published: (2008)
Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects
by: Mathavan, S., et al.
Published: (2017)
by: Mathavan, S., et al.
Published: (2017)
Bile acids and probiotics could help treating diabetes
by: Calasan, J., et al.
Published: (2012)
by: Calasan, J., et al.
Published: (2012)
Thyroid autoimmunity and autoimmune thyroid disease in Malaysian girls with Turner syndrome: an understudied population
by: Lee, Yee L, et al.
Published: (2023)
by: Lee, Yee L, et al.
Published: (2023)
The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs
by: Stojancevic, M., et al.
Published: (2013)
by: Stojancevic, M., et al.
Published: (2013)
THE EFFECT OF BILE ACID SALT SODIUM 3ALPHA, 7ALPHA-DIHYDROXY-12-KETO-5BETA-CHOLANATE (MKC) AND PROBIOTIC PRETREATMENT ON GLICLAZIDE PERMEATION IN ILEAL TISSUES FROM HEALTHY AND DIABETIC RATS
by: Mikov, M., et al.
Published: (2014)
by: Mikov, M., et al.
Published: (2014)
Autoimmune Diseases and Gut Symbionts: The Unpopular Liaison
by: Nor Effa, Zulkafli, et al.
Published: (2019)
by: Nor Effa, Zulkafli, et al.
Published: (2019)
Dried Blood Spot: Utilizing Dry Blood For Pharmacokinetic Investigations—An Old Method with Great Future for Therapeutic Drug Monitoring
by: Maksimovic, V., et al.
Published: (2017)
by: Maksimovic, V., et al.
Published: (2017)
Probiotics as a Promising Treatment for Inflammatory Bowel Disease
by: Mikov, Momir, et al.
Published: (2014)
by: Mikov, Momir, et al.
Published: (2014)
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
by: Danic, M., et al.
Published: (2018)
by: Danic, M., et al.
Published: (2018)
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013)
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2013)
Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring
by: Golocorbin-Kon, S., et al.
Published: (2018)
by: Golocorbin-Kon, S., et al.
Published: (2018)
Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics
by: Al-Salami, Hani, et al.
Published: (2008)
by: Al-Salami, Hani, et al.
Published: (2008)
Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014)
by: Stojancevic, M., et al.
Published: (2014)
Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009)
by: Al-Salami, Hani, et al.
Published: (2009)
Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study
by: Mooranian, A., et al.
Published: (2015)
by: Mooranian, A., et al.
Published: (2015)
Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration
by: Lalic-Popovic, M., et al.
Published: (2013)
by: Lalic-Popovic, M., et al.
Published: (2013)
Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat
by: Lalic-Popovic, M., et al.
Published: (2013)
by: Lalic-Popovic, M., et al.
Published: (2013)
Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women
by: Lalic-Popovic, M., et al.
Published: (2013)
by: Lalic-Popovic, M., et al.
Published: (2013)
Antinuclear antibodies in non-systemic autoimmune rheumatic
disease dermatological conditions
by: Mahayidin, Hasni, et al.
Published: (2021)
by: Mahayidin, Hasni, et al.
Published: (2021)
Eosinophilia in autoimmune hepatitis: is there an association?
by: Mustafa, Ahmad Suhaimi, et al.
Published: (2011)
by: Mustafa, Ahmad Suhaimi, et al.
Published: (2011)
Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families
by: Kuo, Chang-Fu, et al.
Published: (2015)
by: Kuo, Chang-Fu, et al.
Published: (2015)
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
by: Golocorbin-Kon, S., et al.
Published: (2017)
by: Golocorbin-Kon, S., et al.
Published: (2017)
Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
by: Pavlovic, N., et al.
Published: (2018)
by: Pavlovic, N., et al.
Published: (2018)
The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes
by: Mikov, M., et al.
Published: (2017)
by: Mikov, M., et al.
Published: (2017)
Lamotrigine and valproate pharmacokinetics interactions in epileptic patients
by: Lalic, M., et al.
Published: (2009)
by: Lalic, M., et al.
Published: (2009)
Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
by: Mooranian, A., et al.
Published: (2018)
by: Mooranian, A., et al.
Published: (2018)
Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses
by: Mooranian, A., et al.
Published: (2018)
by: Mooranian, A., et al.
Published: (2018)
Screening for antidiabetic activities
by: Caccetta, Rima, et al.
Published: (2013)
by: Caccetta, Rima, et al.
Published: (2013)
Intestinal lymphatic transport of cannabinoids: implications for people with autoimmune diseases and immunocompromised individuals
by: Zgair, Atheer
Published: (2017)
by: Zgair, Atheer
Published: (2017)
Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes
by: Lalic-Popovic, M., et al.
Published: (2015)
by: Lalic-Popovic, M., et al.
Published: (2015)
The Effect of Diabetes and Hypertension on the Placental Permeation of the Hydrophilic Drug, Ranitidine
by: Lalic-Popovic, M., et al.
Published: (2016)
by: Lalic-Popovic, M., et al.
Published: (2016)
Investigation of the curative effects of palm vitamin E tocotrienols on autoimmune arthritis disease in vivo
by: Zainal, Zaida, et al.
Published: (2019)
by: Zainal, Zaida, et al.
Published: (2019)
Potential impacts of Covid-19 on autoimmune diseases: a case report on Systemic Sclerosis
by: Mahayidin, Hasni, et al.
Published: (2024)
by: Mahayidin, Hasni, et al.
Published: (2024)
Probiotic for poultry disease
by: Ho, Yin Wan
Published: (2005)
by: Ho, Yin Wan
Published: (2005)
Autoimmunity in the pathogenesis of severe dengue / Nurhafiza Zainal
by: Nurhafiza, Zainal
Published: (2018)
by: Nurhafiza, Zainal
Published: (2018)
Analysis of candidate retinal autoantigens in autoimmune uveitis
by: Morgan, James
Published: (2005)
by: Morgan, James
Published: (2005)
Necrotizing autoimmune myopathy: a case series
by: Sulaiman Sahari, Narisa, et al.
Published: (2020)
by: Sulaiman Sahari, Narisa, et al.
Published: (2020)
Similar Items
-
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2012) -
Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017) -
Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats
by: Al-Salami, Hani, et al.
Published: (2008) -
Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects
by: Mathavan, S., et al.
Published: (2017) -
Bile acids and probiotics could help treating diabetes
by: Calasan, J., et al.
Published: (2012)